Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Kirk McCullough

Sports Medicine Leawood, KS Medical Doctor

NPI 1215131701 CMS profile 1251469

3651 College Blvd Ste 100A, Suite 100A, Leawood, KS 66211

Open in the dashboard

General payments

$649,191

717 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Kirk McCullough of Leawood, KS is reported in the CMS Open Payments database as having received $649,191 across 717 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $33,861 32
2024 General $60,796 38
2023 General $54,793 68
2022 General $117,084 148
2021 General $85,482 112
2020 General $115,913 94
2019 General $181,261 225

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kirk McCullough
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to Kirk McCullough were reported at $33,861. Among 2,404 Sports Medicine profiles paid that year, the median was $664 and the middle half received between $172 and $3,055.

Show as a table
Year Kirk McCullough Sports Medicine median Middle half National median
2019 $181,261 $1,176 $199–$4,249 $163
2020 $115,913 $708 $96–$2,890 $114
2021 $85,482 $1,213 $152–$3,994 $132
2022 $117,084 $1,230 $159–$3,998 $149
2023 $54,793 $584 $146–$2,836 $160
2024 $60,796 $628 $163–$3,168 $164
2025 $33,861 $664 $172–$3,055 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Arthrex, Inc. $503,168 584 payments
  2. Celularity, Inc. $53,095 24 payments
  3. Djo, LLC $36,240 33 payments
  4. Anika Therapeutics, Inc. $31,249 34 payments
  5. MedShape, Inc. $18,786 16 payments
  6. Titan Surgical Group, LLC $2,035 6 payments
  7. Trilliant Surgical LLC. $1,503 5 payments
  8. Goode Surgical Inc $1,301 1 payment
  9. CGG Medical Inc $912 3 payments
  10. Stryker Corporation $263 3 payments
  11. Other $640 8 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $393,135 101 payments
  2. Consulting Fee $175,494 66 payments
  3. Travel and Lodging $61,442 233 payments
  4. Food and Beverage $9,461 313 payments
  5. Honoraria $7,125 1 payment
  6. Education $2,501 2 payments
  7. Royalty or License $32 1 payment
Products named General payments · program years 2019–2025
  1. Interfyl $35,636 17 payments
  2. Biovance $35,446 15 payments
  3. DynaNail $17,532 12 payments
  4. DynaNail Helix, Washer, 15 mm $17,448 11 payments
  5. PROCARE $17,281 17 payments
  6. Hyalofast $11,548 13 payments
  7. BIOLOGICS CONSUMABLES BONE REPAIR CELLULAR BONE GRAFTING KIT $9,200 2 payments
  8. CMF OL1000 $7,177 3 payments
  9. CMF SPINALOGIC $7,177 3 payments
  10. Hylofast $6,500 2 payments
  11. Other $27,469 54 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

258

Median for Orthopedic Surgery: 203

Drug cost

$1,249

Median for Orthopedic Surgery: $1,433

Branded share of claims

31.8%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 41 $422
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 41 $270
Meloxicam Generic 67 $214
Doxycycline Hyclate Generic 13 $123
Cephalexin Generic 71 $103
Celecoxib Generic 14 $88
Tramadol Hcl Generic 11 $30

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 54 billing codes

Paid by Medicare

$109,789

Of which drugs: $9,582

Medicare patients

276

Average age 73

Services billed

1,194

170 women, 106 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 72%
High blood pressure 64%
Osteoporosis 22%
Ischemic heart disease 21%
Depression 19%
Diabetes 15%
Cancer 14%
Atrial fibrillation 11%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose J7323 Office 19 101 $9,498
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 Office 11 15 $84

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

717 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in Kansas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record